<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32152116</article-id>
<article-id pub-id-type="pmc">7104369</article-id>
<article-id pub-id-type="publisher-id">201911816</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1911816117</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Immunology and Inflammation</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>CD300f immunoreceptor is associated with major depressive disorder and decreased microglial metabolic fitness</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lago</surname>
<given-names>Natalia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kaufmann</surname>
<given-names>Fernanda N.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Negro-Demontel</surname>
<given-names>María Luciana</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alí-Ruiz</surname>
<given-names>Daniela</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ghisleni</surname>
<given-names>Gabriele</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rego</surname>
<given-names>Natalia</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Arcas-García</surname>
<given-names>Andrea</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vitureira</surname>
<given-names>Nathalia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>g</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jansen</surname>
<given-names>Karen</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Souza</surname>
<given-names>Luciano M.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Silva</surname>
<given-names>Ricardo A.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lara</surname>
<given-names>Diogo R.</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>h</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pannunzio</surname>
<given-names>Bruno</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abin-Carriquiry</surname>
<given-names>Juan Andrés</given-names>
</name>
<xref ref-type="aff" rid="aff9">
<sup>i</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Amo-Aparicio</surname>
<given-names>Jesús</given-names>
</name>
<xref ref-type="aff" rid="aff10">
<sup>j</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martin-Otal</surname>
<given-names>Celia</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Naya</surname>
<given-names>Hugo</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McGavern</surname>
<given-names>Dorian B.</given-names>
</name>
<xref ref-type="aff" rid="aff11">
<sup>k</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sayós</surname>
<given-names>Joan</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-7615-9550</contrib-id>
<name>
<surname>López-Vales</surname>
<given-names>Rubèn</given-names>
</name>
<xref ref-type="aff" rid="aff10">
<sup>j</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-0258-6204</contrib-id>
<name>
<surname>Kaster</surname>
<given-names>Manuella P.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-6111-8668</contrib-id>
<name>
<surname>Peluffo</surname>
<given-names>Hugo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>2</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>Neuroinflammation and Gene Therapy Laboratory, <institution>Institut Pasteur de Montevideo</institution>, 11400 Montevideo, <country>Uruguay</country>;</aff>
<aff id="aff2"><sup>b</sup>Department of Biochemistry, <institution>Federal University of Santa Catarina</institution>, Florianópolis, 88040-900 Santa Catarina, <country>Brazil</country>;</aff>
<aff id="aff3"><sup>c</sup>Departamento de Histología y Embriología, Facultad de Medicina, <institution>Universidad de la República</institution>, 11200 Montevideo, <country>Uruguay</country>;</aff>
<aff id="aff4"><sup>d</sup>Department of Life and Health Sciences, <institution>Catholic University of Pelotas</institution>, 96015-560 Rio Grande do Sul, <country>Brazil</country>;</aff>
<aff id="aff5"><sup>e</sup>Bioinformatics Unit, <institution>Institut Pasteur de Montevideo</institution>, 11400 Montevideo, <country>Uruguay</country>;</aff>
<aff id="aff6"><sup>f</sup>Immune Regulation and Immunotherapy Group, CIBBIM-Nanomedicine, Vall d’Hebrón Institut de Recerca, <institution>Universitat Autònoma de Barcelona</institution>, 08193 Barcelona, <country>Spain</country>;</aff>
<aff id="aff7"><sup>g</sup>Department of Physiology, Facultad de Medicina, <institution>Universidad de la República</institution>, 11200 Montevideo, <country>Uruguay</country>;</aff>
<aff id="aff8"><sup>h</sup>Department of Cellular and Molecular Biology, <institution>Pontifical Catholic University of Rio Grande do Sul</institution>, 90619-900 Porto Alegre, <country>Brazil</country>;</aff>
<aff id="aff9"><sup>i</sup><institution>Instituto de Investigaciones Biológicas Clemente Estable</institution>, 11600 Montevideo, <country>Uruguay</country>;</aff>
<aff id="aff10"><sup>j</sup>Departament de Biologia Cel·lular, Fisiologia i Immunologia, Institut de Neurociències, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, <institution>Universitat Autònoma de Barcelona</institution>, 08193 Bellaterra, <country>Spain</country>;</aff>
<aff id="aff11"><sup>k</sup>Viral Immunology and Intravital Imaging Section, National Institute for Neurological Disorders and Stroke, <institution>National Institutes of Health</institution>, Bethesda, <addr-line>MD</addr-line> 20892</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>2</sup>To whom correspondence may be addressed. Email: <email>hugo.peluffo@pasteur.edu.uy</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Shizuo Akira, Osaka University, Osaka, Japan, and approved February 4, 2020 (received for review July 11, 2019)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: N.L., F.N.K., G.G., N.R., N.V., J.A.-A., H.N., D.B.M., J.S., R.L.-V., M.P.K., and H.P. designed research; N.L., F.N.K., M.L.N.-D., D.A.-R., G.G., N.R., A.A.-G., N.V., K.J., L.M.S., R.A.S., D.R.L., B.P., J.A.A.-C., J.A.-A., C.M.-O., J.S., M.P.K., and H.P. performed research; N.L., M.L.N.-D., N.R., N.V., H.N., D.B.M., J.S., and R.L.-V. contributed new reagents/analytic tools; N.L., F.N.K., M.L.N.-D., D.A.-R., G.G., N.R., A.A.-G., N.V., J.A.-A., H.N., J.S., R.L.-V., M.P.K., and H.P. analyzed data; and N.L., F.N.K., N.R., M.P.K., and H.P. wrote the paper.</p>
</fn>
<fn fn-type="equal" id="fn1">
<p><sup>1</sup>N.L and F.N.K. contributed equally to this work.</p>
</fn>
<fn fn-type="COI-statement">
<p>The authors declare no competing interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>24</day>
<month>3</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>9</day>
<month>3</month>
<year>2020</year>
</pub-date>
<volume>117</volume>
<issue>12</issue>
<fpage>6651</fpage>
<lpage>6662</lpage>
<permissions>
<copyright-year>2020</copyright-year>
<license>
<ali:license_ref specific-use="vor" xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://www.pnas.org/site/aboutpnas/licenses.xhtml</ali:license_ref>
<license-p>Published under the <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/site/aboutpnas/licenses.xhtml">PNAS license</ext-link>.</license-p>
</license>
</permissions>
<self-uri xlink:href="pnas.201911816.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>A role for innate immune receptors expressed by microglia and barrier macrophages has been postulated in neuropsychiatric diseases, including major depressive disorder (MDD). We discovered that a prevalent single-nucleotide polymorphism of the human CD300f immune receptor alters its signaling and is associated with protection against MDD in women but not in men. Interestingly, CD300f-deficient female, but not male, mice displayed depressive-like behaviors. In these mice, the absence of CD300f induced phenotypical changes of microglial cells that altered their metabolic fitness. Despite the high incidence of MDD, no effective treatments are available in many cases, and these discoveries could lead to the development of new pipelines for drugs targeting microglial cells, perivascular macrophages, and in particular the CD300f immune receptor.</p>
</abstract>
<abstract>
<p>A role for microglia in neuropsychiatric diseases, including major depressive disorder (MDD), has been postulated. Regulation of microglial phenotype by immune receptors has become a central topic in many neurological conditions. We explored preclinical and clinical evidence for the role of the CD300f immune receptor in the fine regulation of microglial phenotype and its contribution to MDD. We found that a prevalent nonsynonymous single-nucleotide polymorphism (C/T, rs2034310) of the human CD300f receptor cytoplasmic tail inhibits the protein kinase C phosphorylation of a threonine and is associated with protection against MDD, mainly in women. Interestingly, CD300f<sup>−/−</sup> mice displayed several characteristic MDD traits such as augmented microglial numbers, increased interleukin 6 and interleukin 1 receptor antagonist messenger RNA, alterations in synaptic strength, and noradrenaline-dependent and persistent depressive-like and anhedonic behaviors in females. This behavioral phenotype could be potentiated inducing the lipopolysaccharide depression model. RNA sequencing and biochemical studies revealed an association with impaired microglial metabolic fitness. In conclusion, we report a clear association that links the function of the CD300f immune receptor with MDD in humans, depressive-like and anhedonic behaviors in female mice, and altered microglial metabolic reprogramming.</p>
</abstract>
<kwd-group>
<kwd>microglia</kwd>
<kwd>RNA-seq</kwd>
<kwd>depression</kwd>
<kwd>immunereceptor</kwd>
<kwd>CD300</kwd>
</kwd-group>
<counts>
<page-count count="12"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>